Back to results
US 6,350,755 B1Granted
Inhibitors of prenyl-protein transferase
AssigneeMerck & Co., Inc.
InventorsS. Jane deSolms, Anthony W. Shaw
Life of this patent
Estimating the term…
Abstract
The present invention is directed to peptidomimetic macrocyclic compounds which inhibit prenyl-protein transferase and the prenylation of the oncogene protein Ras. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for inhibiting prenyl-protein transferase and the prenylation of the oncogene protein Ras.
Claims18
A compound of the formula D:
- wherein:
- R1b and R1c are independently selected from hydrogen or C1-C6 alkyl;
- R1d is selected from:
- a) hydrogen,
- b) C1-C6 alkyl;
- R1e is independently selected from:
- a) hydrogen,
- b) aryl, heterocycle, C3-C10 cycloalkyl, R10O—, —N(R10)2 or C2-C6 alkenyl, and
- c) C1-C6 alkyl, C2-C6 alkenyl or C2-C6 alkynyl, unsubstituted or substituted by aryl, heterocycle, C3-C10 cycloalkyl, C2-C6 alkenyl, R10O—, or —N(R10)2;
- R4 is C1-4 alkyl;
- R6 and R7 are independently selected from:
- a) hydrogen,
- b) C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, R10C(O)— or R10OC(O)— and
- c) C1-C6 alkyl substituted by C1-C6 perfluoroalkyl, R10O—, R10C(O)NR10—, (R10)2N—C(NR10)—, R10C(O)—, R10OC(O)—, —N(R10)2, or R11OC(O)NR10—;
- R8 is independently selected from:
- a) hydrogen,
- b) unsubstituted or substituted aryl, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C1-C6 perfluoroalkyl, F, Cl, R12O—, R10C(O)NR10—, CN, NO2, (R10)2N—C(NR10)—, R10C(O)—, —N(R10)2, or R11OC(O)NR10—, and
- c) C1-C6 alkyl substituted by unsubstituted or substituted aryl, C1-C6 perfluoroalkyl, R10O—, R10C(O)NR10—, (R10)2N—C(NR10)—, R10C(O)—, —N(R10)2, or R11OC(O)NR10—;
- R9a is selected from hydrogen, C1-C6 alkyl and C1-C6 perfluoroalkyl;
- R10 and R12 are independently selected from hydrogen, C1-C6 alkyl, benzyl and unsubstituted or substituted aryl;
- R11 is independently selected from C1-C6 alkyl and unsubstituted or substituted aryl;
- A1 is selected from a bond, —N(R10)—, S(O)m and O;
- X is selected from a bond, —C(O)— and S(O)2;
- Y is selected from:
- —C(O)—, —C(O)NR10—, —NR10C(O)—, —NR10C(O)NR10—, O, —N(R10)—, —S(O)2N(R10)—, —N(R10)S(O)2—, and S(O)m;
- Z1 is selected from unsubstituted or substituted phenyl or unsubstituted or substituted naphthyl, wherein the substituted phenyl or substituted naphthyl is substituted with one or two of:
- 1) C1-4 alkyl, unsubstituted or substituted with:
- a) C1-4 alkoxy,
- b) NR6R7,
- c) C3-6 cycloalkyl,
- d) aryl or heterocycle,
- e) HO,
- f) —S(O)mR4, or
- g) —C(O)NR6R7,
- 2) phenyl, pyridyl, imidazolyl, oxazolyl, isoxazolyl, thiazolyl, thienyl, furyl or isothiazolyl,
- 3) halogen,
- 4) OR6,
- 5) NR6R7,
- 6) CN,
- 7) NO2,
- 8) CF3,
- 9) —S(O)mR4,
- 10) —C(O)NR6R7, or
- 11) C3-C6 cycloalkyl;
- m is 0, 1 or 2;
- n is 0 or 1;
- r is 0 to 5;
- s is independently 0, 1, 2 or 3;
- and
- t is 1, 2, 3 or 4;
- or a pharmaceutically acceptable salt or stereoisomer thereof.
48 more elements
A compound which is:
- or a pharmaceutically acceptable salt or stereoisomer thereof.
Dependencies are inferred from the claim text.